Company: BIAF
Filing Date: 2025-05-23
Form Type: PRER14A
Source: 0001641172-25-012315
Chunk: 56

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-23
Form: PRER14A
Chunk 56
---
The affirmative vote from the holders of a majority of the shares present in person or represented by proxy and entitled to vote on the Anti-Dilution Adjustment Proposal at the Annual Meeting is required for approval of this proposal. Abstentions will have the same effect as votes AGAINST this proposal. Broker non-votes will have no effect on this proposal.

Approval by our stockholders of this Anti-Dilution Adjustment Proposal is not conditioned upon approval by our stockholders of the Authorized Increase Proposal (Proposal No. 5).

<div align='center'>THE BOARD UNANIMOUSLY RECOMMENDS

AVOTE “FOR” APPROVAL OF THE

ANTI-DILUTION ADJUSTMENT PROPOSAL.</div>

| 28 |

<div align='center'>PROPOSAL NO. 7

APPROVAL OF THE ADJOURNMENT PROPOSAL</div>

Background of and Rationale for the Adjournment Proposal

The Board of Directors believes that if the number of shares of our Common Stock outstanding and entitled to vote at the Annual Meeting is insufficient to approve the Reverse Stock Split Proposal, the Warrant Exercise Proposal, the Authorized Increase Proposal, and/or the Anti-Dilution Adjustment Proposal, it is in the best interests of the stockholders to enable the Board to continue to seek to obtain a sufficient number of additional votes to approve the Reverse Stock Split Proposal, the Warrant Exercise Proposal, the Authorized Increase Proposal, and/or the Anti-Dilution Adjustment Proposal.

In the Adjournment Proposal, we are asking stockholders to authorize the holder of any proxy solicited by the Board to vote in favor of adjourning or postponing the Annual Meeting or any adjournment or postponement thereof. If our stockholders approve this proposal, we could adjourn or postpone the Annual Meeting, and any adjourned session of the Annual Meeting, to use the additional time to solicit additional proxies in favor of the Reverse Stock Split Proposal, the Warrant Exercise Proposal, the Authorized Increase Proposal, and/or the Anti-Dilution Adjustment Proposal.

Additionally, approval of the Adjournment Proposal could mean that, in the event we receive proxies indicating that holders of a majority of the number of shares present in person or represented by proxy at the Annual Meeting will vote against the Reverse Stock Split Proposal, the Warrant Exercise Proposal, the Authorized Increase Proposal, and/or Anti-Dilution Adjustment Proposal, we could adjourn or postpone the Annual Meeting without a vote on the Reverse Stock Split Proposal, the Warrant Exercise Proposal, the Authorized